Company Profiles

driven by the PitchBook Platform

Carmell Therapeutics

Description

Developer of medical devices manufactured from blood plasma. The company's proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue.

2007

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$1.47M

Latest Deal Amount

$5.78M

Total Amount Raised

Description

Developer of medical devices manufactured from blood plasma. The company's proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue.

Website:

www.carmellrx.com

Formerly Known As

CarMell

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Primary Office

3636 Boulevard of the Allies Pittsburgh, PA 15213United States +1 (412) 508-6519
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Carmell Therapeutics's full profile, request a free trial.

Carmell Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Carmell Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Carmell Therapeutics Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
Harbor Light Capital PartnersVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Innovation WorksVenture CapitalMinority000 0000000 0000
Ariel Southeast Angel Partners Angel Group
BlueTree Allied Angels Venture Capital
Harbor Light Capital Partners Venture Capital
Individual Investor Angel (individual)
Innovation Works Venture Capital

Carmell Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Randy HubbellChief Executive Officer & President
Alan WestChief Operating Officer
Phil Campbell Ph.DCo-Founder & Chief Scientific Officer
Donna GodwardChief Quality Officer
James Burgess MDCo-Founder
Randy Hubbell Chief Executive Officer & President
Alan West Chief Operating Officer
Phil Campbell Ph.D Co-Founder & Chief Scientific Officer
Donna Godward Chief Quality Officer
James Burgess MD Co-Founder

Carmell Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
James JordanPittsburgh Life Sciences GreenhouseChief Investment Officer, Vice President & Board Member000 0000
Paul KornblithSelfCo-Chairman000 0000
Richard UptonHarbor Light Capital PartnersGeneral Partner000 0000
William Newlin Ph.DNewlin Investment CompanyChairman000 0000
James Jordan Chief Investment Officer, Vice President & Board Member Pittsburgh Life Sciences Greenhouse
Paul Kornblith Co-Chairman Self
Richard Upton General Partner Harbor Light Capital Partners
William Newlin Ph.D Chairman Newlin Investment Company
Request full access to PitchBook